μg/ml BALF | μg/μg BALF albumin | μg/ml ELF | mg/g total BALF protein | Ratio BALF/serum (×10−3) | |
---|---|---|---|---|---|
Controls | 3.0 (0.4)15 | 0.2 (0.0)15 | 622.2 (166.5)15 | 39.6 (5.6)7 | 5.3 (0.9)21 |
2.5 (0.7)7 | 0.1 (0.0)17 | 342.2 (42.1)19 | |||
0–5.716a | 0.1 (0.1)b 18 | 409.7 (64.4)20 | |||
2.8–0.72-a | |||||
4.8 (1.4)24 | |||||
Asymptomatic smokers | 4.2 (1.2)7 | 65.9 (14.2)7 | |||
2.8 (0.3)23 | |||||
Symptomatic smokers | 1.7 (0.4)15 | 0.1 (0.0)15 | 433.6 (168.8)15 | 35.1 (5.1)7 | |
4.0 (0.8)7 | 0.1 (0.0)17 | ||||
2.4 (0.3)23 | |||||
Pneumocystis carinii pneumonia | 6.9 (2.8)24 | 0.1 (0.0)24 | 6.3 (0.6)21 | ||
Toxic oil syndrome | 0.1 (0.0)b 18 | ||||
Sarcoidosis | 34.9 (14.7)24 | 0.1 (0.0)24 | |||
2.0–22.5a 16 | |||||
Extrinsic allergic alveolitis | 20.7 (9.40)24 | 0.1 (0.0)24 | |||
Cryptogenic fibrosing alveolitis | 4.6 (0.9)24 | 0.1 (0.0)24 | |||
Adenocarcinomatous infiltration of the lung | 12.1 (1.9)24 | 0.1 (0.0)24 | |||
Tuberculosis | 7.17 (1.57)24 | 0.1 (0.0)24 | |||
Chronic obstructive pulmonary disease | 1.5 (0.2)25 | ||||
Adult respiratory distress syndrome | 15.7 (2.0)25 |
↵2-a Range.
2-b Mean (SD).
Superscript numbers are reference numbers.